Ruffini, P. A., L. Rivoltini, et al. ( 1993). "Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells." Cancer Immunol Immunother 36(6): 409-16. 176. Sabbatini, P., P. Harter, et al. (2013) . "Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer : A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO--The MIMOSA Study." J Clin Oncol 31(12): 1554- 61. 177. Salgia, R., T. Lynch, et al. (2003). "Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage col ony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma." J Clin Oncol 21(4): 624-30. 178.